News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,972 Results
Type
Article (163)
Company Profile (1)
Press Release (1808)
Section
Business (704)
Career Advice (1)
Deals (109)
Drug Development (323)
Employer Resources (4)
FDA (64)
Job Trends (40)
News (1203)
Policy (109)
Tag
Academia (2)
Adcomms (1)
Alliances (162)
Alzheimer's disease (1)
Antibody-drug conjugate (ADC) (12)
Approvals (69)
Artificial intelligence (4)
ASCO (2)
Bankruptcy (1)
Best Places to Work (23)
Biotechnology (1)
Brain cancer (1)
Cancer (28)
Career advice (1)
Clinical research (325)
Collaboration (10)
C-suite (13)
Data (37)
Diagnostics (6)
Diversity, equity & inclusion (1)
Drug discovery (2)
Earnings (291)
Employer branding (1)
Employer resources (3)
Events (213)
Executive appointments (11)
FDA (79)
Fibrodysplasia Ossificans Progressiva (1)
Funding (3)
GLP-1 (3)
Government (9)
Guidances (6)
Healthcare (26)
Hematology (4)
Immunology and inflammation (1)
Immuno-oncology (1)
Indications (1)
Infectious disease (1)
IPO (47)
Job creations (18)
Job search strategy (1)
Kidney cancer (1)
Layoffs (7)
Legal (6)
Lymphoma (3)
Management (1)
MASH (3)
Medical device (1)
Medtech (1)
Mergers & acquisitions (70)
Metabolic disorders (4)
Neurodegenerative disease (1)
Neuroscience (4)
NextGen: Class of 2026 (9)
Non-profit (7)
Obesity (1)
Opinion (1)
Pancreatic cancer (3)
People (300)
Phase 1 (60)
Phase 2 (102)
Phase 3 (186)
Pipeline (55)
Policy (2)
Postmarket research (3)
Preclinical (12)
Prostate cancer (2)
Psychedelics (1)
Rare diseases (9)
Real estate (14)
Recruiting (1)
Regulatory (115)
Research institute (2)
RSV (1)
Series A (2)
Sickle cell disease (1)
Startups (15)
The Weekly (1)
Venture capital (1)
Date
Last 7 days (3)
Last 30 days (10)
Last 365 days (131)
2026 (76)
2025 (109)
2024 (115)
2023 (146)
2022 (198)
2021 (164)
2020 (146)
2019 (126)
2018 (103)
2017 (107)
2016 (79)
2015 (79)
2014 (74)
2013 (50)
2012 (62)
2011 (65)
2010 (69)
Location
Africa (2)
Asia (59)
Australia (3)
California (40)
Canada (9)
China (5)
Europe (985)
Florida (1)
Illinois (5)
Japan (1)
Maryland (3)
Massachusetts (64)
New Jersey (3)
New York (4)
Northern California (31)
Pennsylvania (1)
South America (3)
Southern California (3)
Texas (2)
United States (124)
Wisconsin (1)
1,972 Results for "ipsen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Ipsen makes up to $1.75B blood cancer bet with Kartos buyout
The star of Ipsen’s acquisition is an MDM2 blocker being proposed as an add-on therapy to ruxolitinib for myelofibrosis. The drug could be available to patients “as early as 2028,” according to Ipsen CEO David Loew.
June 29, 2026
·
2 min read
·
Tristan Manalac
Cancer
Ipsen Pulls Cancer Drug Amid Risk of Secondary Malignancies
Ipsen will withdraw Tazverik’s follicular lymphoma and epithelioid sarcoma indications as emerging data point to an elevated safety risk in patients undergoing treatment.
March 9, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Ipsen announces the launch of an Employee Shareholding Plan
June 1, 2026
·
7 min read
Press Releases
Ipsen to acquire Kartos Therapeutics, expanding hemato-oncology late-stage pipeline
June 29, 2026
·
12 min read
Press Releases
IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2026
June 9, 2026
·
1 min read
Press Releases
Ipsen S.A. – Evolution of the composition of the Board of Directors
May 14, 2026
·
5 min read
Press Releases
Ipsen initiates a new share buy-back program - May 18, 2026
May 18, 2026
·
5 min read
Press Releases
Annual General Meeting of Ipsen S.A. held on 13 May 2026
May 14, 2026
·
6 min read
Press Releases
Ipsen unveils corabotase, a first-in-class recombinant neuroinhibitor, RNI™, at the SCALE Symposium
May 14, 2026
·
7 min read
Press Releases
Ipsen announces the availability of its 2025 Universal Registration Document
April 2, 2026
·
5 min read
1 of 198
Next
